UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

**FORM N-Q**

**QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED**

**MANAGEMENT INVESTMENT COMPANY**

**_______________________________**

Investment Company Act file number  811-2021

DWS Securities Trust

(Exact name of registrant as specified in charter)

 

345 Park Avenue

New York, NY  10154-0004

(Address of principal executive offices)             (Zip code)

 

Paul Schubert

345 Park Avenue

New York, NY  10154-0004

(Name and address of agent for service)

Registrant's telephone number, including area code:  (212) 454-7190

Date of fiscal year end:  05/31

Date of reporting period: 02/29/08

 

ITEM 1.  SCHEDULE OF INVESTMENTS

 

| Investment Portfolio | **as of February 29, 2008  (Unaudited)** |
|----------------------|------------------------------------------|

 

 

**DWS Health Care Fund**

 

|   | **Shares**              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | **Value ($)** |
|--------|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|
|        |
|   | **Common Stocks 98.7%** |  
**Health Care 98.7%**

 
**Biotechnology 21.4%**

 
Acorda Therapeutics, Inc.*  

 

23,500 

 

480,340 

Alexion Pharmaceuticals, Inc.*  

 

30,400 

 

1,842,544 

Amgen, Inc.*  

 

61,200 

 

2,785,824 

Amylin Pharmaceuticals, Inc.*  

 

11,100 

 

293,817 

Applera Corp. - Celera Group*  

 

143,900 

 

1,994,454 

Biogen Idec, Inc.*  

 

61,695 

 

3,600,520 

BioMarin Pharmaceutical, Inc.* (a) 

 

85,200 

 

3,241,008 

Celgene Corp.*  

 

73,000 

 

4,115,010 

Cepheid, Inc.* (a) 

 

58,500 

 

1,619,280 

Gen-Probe, Inc.*  

 

20,100 

 

960,981 

 

 

 

 

Genentech, Inc.*  

 

53,800 

 

4,075,350 

Genmab A/S* (a) 

 

18,700 

 

1,102,909 

Genzyme Corp.*  

 

62,000 

 

4,397,040 

Gilead Sciences, Inc.*  

 

127,000 

 

6,009,640 

Illumina, Inc.*  

 

7,700 

 

557,557 

Keryx Biopharmaceuticals, Inc.* (a) 

 

55,800 

 

320,850 

Luminex Corp.* (a) 

 

44,200 

 

769,522 

Medarex, Inc.* (a) 

 

57,100 

 

531,030 

Millennium Pharmaceuticals, Inc.*  

 

82,200 

 

1,149,978 

Myriad Genetics, Inc.* (a) 

 

21,200 

 

784,824 

Onyx Pharmaceuticals, Inc.*  

 

22,600 

 

617,432 

OSI Pharmaceuticals, Inc.*  

 

13,300 

 

478,135 

PDL BioPharma, Inc.*  

 

86,400 

 

1,380,672 

Regeneron Pharmaceuticals, Inc.* (a) 

 

62,900 

 

1,243,533 

United Therapeutics Corp.* (a) 

 

12,500 

 

1,052,125 

Vertex Pharmaceuticals, Inc.*  

 

29,500 

 

516,250 

 

**45,920,625**

**Health Care Services 21.3%**

 
Aetna, Inc.  

 

63,000 

 

3,124,800 

Allscripts Healthcare Solutions, Inc.* (a) 

 

83,900 

 

895,213 

Covance, Inc.*  

 

30,800 

 

2,599,828 

CVS Caremark Corp.  

 

104,385 

 

4,215,066 

Express Scripts, Inc.*  

 

50,800 

 

3,002,280 

Fresenius Medical Care AG & Co. KGaA  

 

62,523 

 

3,282,025 

Henry Schein, Inc.*  

 

36,400 

 

2,177,448 

Laboratory Corp. of America Holdings*  

 

47,000 

 

3,633,570 

McKesson Corp.  

 

67,200 

 

3,948,672 

Medco Health Solutions, Inc.*  

 

68,652 

 

3,041,970 

Pharmaceutical Product Development, Inc.  

 

62,000 

 

2,794,340 

Quality Systems, Inc. (a) 

 

70,200 

 

2,287,116 

Quest Diagnostics, Inc.  

 

61,500 

 

2,931,705 

TriZetto Group, Inc.*  

 

62,300 

 

1,216,096 

UnitedHealth Group, Inc.  

 

71,520 

 

3,324,250 

WellPoint, Inc.*  

 

44,400 

 

3,111,552 

 

**45,585,931**

**Life Sciences Equipment 4.3%**

 
Applera Corp. - Applied Biosystems Group  

 

33,700 

 

1,136,027 

Charles River Laboratories International, Inc.*  

 

17,800 

 

1,042,724 

Thermo Fisher Scientific, Inc.*  

 

126,700 

 

7,086,331 

 

**9,265,082**

**Medical Supply & Specialty 22.3%**

 
Alcon, Inc.  

 

24,100 

 

3,487,993 

Align Technology, Inc.* (a) 

 

38,800 

 

479,180 

ArthroCare Corp.* (a) 

 

50,400 

 

2,023,560 

Baxter International, Inc.  

 

106,000 

 

6,256,120 

Beckman Coulter, Inc.  

 

17,400 

 

1,174,500 

Becton, Dickinson & Co.  

 

52,900 

 

4,783,218 

C.R. Bard, Inc.  

 

62,000 

 

5,876,980 

Covidien Ltd.  

 

74,000 

 

3,166,460 

Hologic, Inc.*  

 

67,600 

 

4,076,956 

Medtronic, Inc.  

 

121,600 

 

6,002,176 

Mentor Corp. (a) 

 

23,200 

 

688,112 

NuVasive, Inc.*  

 

40,500 

 

1,560,870 

ResMed, Inc.*  

 

25,700 

 

1,040,593 

 

 

 

 

SonoSite, Inc.* (a) 

 

31,200 

 

918,216 

 
Stryker Corp.  

 

55,300 

 

3,600,583 

 
Zimmer Holdings, Inc.*  

 

33,800 

 

2,544,802 

 
 
 

**47,680,319**

 
**Pharmaceuticals 29.4%**

 
Abbott Laboratories  

 

97,100 

 

5,199,705 

 
Allergan, Inc.  

 

49,800 

 

2,949,654 

 
Astellas Pharma, Inc.  

 

52,800 

 

2,315,933 

 
Barr Pharmaceuticals, Inc.*  

 

24,800 

 

1,169,320 

 
Bristol-Myers Squibb Co.  

 

130,800 

 

2,957,388 

 
Cardiome Pharma Corp.* (a) 

 

58,600 

 

439,500 

 
Eli Lilly & Co.  

 

81,300 

 

4,066,626 

 
Forest Laboratories, Inc.*  

 

24,700 

 

982,319 

 
Johnson & Johnson  

 

78,000 

 

4,832,880 

 
Merck & Co., Inc.  

 

98,200 

 

4,350,260 

 
Merck KGaA  

 

24,314 

 

3,018,703 

 
Mylan, Inc. (a) 

 

185,800 

 

2,199,872 

 
Novartis AG (Registered) (a) 

 

43,018 

 

2,114,304 

 
Pfizer, Inc.  

 

168,750 

 

3,759,750 

 
Pharmion Corp.* (a) 

 

17,400 

 

1,245,666 

 
Roche Holding AG (Genusschein) (a) 

 

35,285 

 

6,929,678 

 
Sanofi-Aventis  

 

30,618 

 

2,269,651 

 
Schering-Plough Corp.  

 

149,000 

 

3,233,300 

 
Shire PLC (ADR)  

 

42,900 

 

2,507,076 

 
Stada Arzneimittel AG  

 

34,300 

 

2,411,159 

 
Wyeth  

 

90,500 

 

3,947,610 

 
 
 

**62,900,354**

 
 
**Total Common Stocks** (Cost $158,916,689)

 

**211,352,311**

 
 

**Securities Lending Collateral 11.2%**

 
Daily Assets Fund Institutional, 3.69%  (b) (c)(Cost $23,952,825)

 

 

23,952,825

 

**23,952,825**

 
 

**Cash Equivalents 1.0%**

 
Cash Management QP Trust, 3.89%  (b)(Cost $2,252,834)

 

 

2,252,834

 

**2,252,834**

 
 

**% of****Net Assets**

 

**Value ($)**

 
 
**Total Investment Portfolio** (Cost $185,122,348) † 

110.9

 

**237,557,970**

 
**Other Assets and Liabilities, Net**

(10.9)

 

**(23,352,414)**

 
 
**Net Assets**

100.0

 

**214,205,556**

 
 

*For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.*

*†*

*The cost for federal income tax purposes was $185,840,144.  At February 29, 2008, net unrealized appreciation for all securities based on tax cost was $51,717,826.  This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $60,714,860 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $8,997,034.*

 
***

*Non-income producing security.*

 
*(a)*

*All or a portion of these securities were on loan.  The value of all securities loaned at February 29, 2008 amounted to $23,265,463 which is 10.9% of net assets.*

 
*(b)*

*Affiliated fund managed by Deutsche Investment Management Americas Inc.  The rate shown is the annualized seven-day yield at period end.*

 
*(c)*

*Represents collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates.*

 
 

 

 

 

*ADR: American Depositary Receipt*

 

 

**ITEM 2.**

**CONTROLS AND PROCEDURES**

 

 

 

(a)          The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

 

 

 

(b)         There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.

 

 

**ITEM 3.**

**EXHIBITS**

 

 

 

Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

 

 

 

**SIGNATURES**

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: 

DWS Health Care Fund, a series of DWS Securities Trust

 

By:

/s/Michael G. Clark

 

Michael G. Clark

President

 

Date:

April 16, 2008

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Registrant: 

DWS Health Care Fund, a series of DWS Securities Trust

 

By:

/s/Michael G. Clark

 

Michael G. Clark

President

 

Date:

April 16, 2008

 

 

By:

/s/Paul Schubert

 

Paul Schubert

Chief Financial Officer and Treasurer

 

Date:                                        April 16, 2008

 

  |